Validity ICT and CLIA of SARS-CoV-2 Antibody
DOI:
https://doi.org/10.24293/ijcpml.v28i2.1773Keywords:
COVID-19, antibody, sensitivity, specificityAbstract
The varying validity of antibody test requires a good diagnostic accuracy analysis in determining the right tome to perform antibody testing in patients. This study is to evaluate sensitivity and specificity of SARS-CoV2 antibody test based on the testing time. This stugy is a cross sectional retrospective diagnostic test study include 960 subject divided into 3 groups based on the testing time using 2 antibody test methods are ICT and CLIA. The sensitivity and specificity of ICT method was 45.8% and 59.7%, while the CLIA method was 81.6% and 74.4%. Based on timing of antibody test after symptom onset, the highest sensitivity was obtained at >15 days of symptom onset (84.4% and 78.7%). Low sensitivity can be caused due to the absence or low antibodies in the first week to second weeks of infection. Sample collection is done 2-4 weeks after symptom onset. The SARS CoV-2 IgM and IgG antibodies have high sensitivity and specificity at onset >15 days (84.4% and 78.7%).Downloads
References
Aryati. Aspek laboratorium COVID-19: Pemeriksaaan serologi dan PCR. Seminar PDS PatKLIn pada 21 Mei 2020. 2020.
Anonim. Coronavirus Diseases (COVID-19) pandemic. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. (accessed October 17, 2020).
Bastos ML, Tavaziva G, Abidi SK, et al. Diagnostic accuracy of serological test for COVID-19 : systematic review and meta-analysis. BMJ. 2020;370. Available from : https://www.bmj.com/content/370/bmj.m2516. (accessed October 14, 2020).
Vengesai A, Midzi H, Kasambala M et al. A ssystematic and meta-analysis review on the diagnostic accuracy of antibodies in the serological diagnosis of COVID-19. Research Square. 2020:1-41. Available from : https://doi.org/10.21203/rs.3.rs-34638/v1. (accessed October 14, 2020).
Xia N, Wang G, Gong W et al. Serological test is an efficient supplement of RNA detection for confirmation of SARS-CoV-2 infection. Preprints. 2020. (accessed October 14, 2020).
Wang H, Ai J, Loeffelholz MJ, Yang YW, Zhang W. Meta-analysis of diagnostic performance of serology test for COVID-19: Impact of assay design and post-symptom-onset intervals. Emerging Microbes & Infections, 2020; 9(1): 2200-2211.
Whitman JD, Hiatt J, Mowery CT, Shy BR, Yu R, Yamamoto TN, et al. Test performance evaluation of SARS CoV-2 serological assays. Infectious Disease; 2020. medRxiv. 2020; 2020.04.25.20074856. Available from: http://medrxiv.org/lookup/doi/10/1101/2020.04.25.20074856. (accessed October 14, 2020).
PP PDS PatKLIn. Hasil survey performa RDT antibodi SARS CoV-2. Juli 2020. Available from: http://pdspatklin.or.id/post/performa-rdt-sars-cov-2-pds-patklin. (accessed Octo 17, 2020).
World Health Organization (WHO). 2020. Advice on the use of point-of-care immunodiagnostic test for COVID-19. Available from : https://www.who.int/news-room/commentaries/detail/advice-on-the-use-of-point-of-care-immunodiagnostic-tests-for-covid-19. (accessed October 14, 2020).
Nath H, Mallick A, Roy S, Sukla S, Basu K, Biswas S, et al. Dengue antibodies can cross-react with SARS-CoV-2 and vice versa-Antibody detection kits can give false-positive results for both viruses in regions where both COVID-19 and Dengue co-exist. medRxiv. 2020.07.03.20145797. Available from : https://doi.org/10.1101/2020.07.03.20145797. (accessed October 17, 2020).
de Moura DTM, McCarty TR, Ribeiro IB, Funari MP, de Oliviveria PVAG, Miranda Neto AA, et al. 2020. Diagnostic Characteristics of Serological-Based COVID-19 : A Systematic Review and Meta-Analysis. Clinics (Sao Paulo). 2020;75:e2212. Available from : https://doi.org/10.6061/clinics/2020/e2212. (accessed October 14, 2020).
Infectious Disease Society America Guidelines on the Diagnosis of COVID-19 : Serologic Testing. Available from : https://www.idsociety.org/COVID19guidelines/serology. (accessed October 14, 2020).
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
